Johnson & Johnson and Legend Biotech’s BCMA-targeted CAR-T therapy Carvykti has been approved by the FDA to treat patients with multiple myeloma after at least one prior therapy. The decision ...
The study – which tested Carvykti in patients with one to three lines of prior therapy – gives J&J an opportunity to leapfrog Bristol-Myers Squibb and 2Seventy bio's rival BCMA CAR-T therapy ...
The Detroit Red Wings' postseason hopes are fading fast after the team looked poised to make a return to the playoffs approximately one month ago. Detroit (33-31-6, 72 points) lost nine of its 11 ...
The Presiding Officer has finally reluctantly deigned to allow the Scottish Parliament to discuss the issues arising from Sandie Peggie vs NHS Fife, in the shape of a debate taking place in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback